Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

Public Comment: Draft Amendment to Ministerial Ordinance on Good Clinical Practice Standards for Pharmaceuticals

医薬品の臨床試験の実施の基準に関する省令等の一部を改正する省令(案)に関する御意見の募集について

Published: 2026-07-31 · Source: e-Gov Public Comment · Stage: Public Comment Closed · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · Comment deadline: 2026-08-30 23:59 JST · First detected by this dashboard: 2026-08-02

View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

Japan's Ministry of Health, Labour and Welfare (Pharmaceutical Safety Bureau, Pharmaceutical Evaluation Division) has opened a public comment period on a draft ministerial ordinance that would partially amend the ordinance concerning standards for conducting clinical trials of pharmaceuticals (Good Clinical Practice) and related provisions. According to the metadata, the draft was published on 2026-07-31 and comments are accepted until 2026-08-30 23:59. This is a draft out for public comment and has not been enacted or brought into force.

Business Impact

Organizations involved in pharmaceutical clinical trials in Japan may want to monitor this proposal, as changes to clinical trial conduct standards could affect trial operations and compliance practices if later adopted.

Recommended Action

Consider reviewing the official Japanese source and the draft ordinance text to understand the proposed changes and the comment submission deadline.

Timeline of related official records

Related official records are linked only when names and instrument numbers match exactly, so this timeline may be incomplete. Dates are as stated by the official sources. It is a monitoring aid, not legal advice; the original Japanese sources are authoritative.

  1. 2026-07-31 — Draft published for public comment (e-Gov) 医薬品の臨床試験の実施の基準に関する省令等の一部を改正する省令(案)に関する御意見の募集について (this update) Original Japanese source
  2. 2026-08-30 — Public comment deadline (2026-08-30 23:59 JST) (this update) Original Japanese source

What happens next

General procedure: after a consultation closes, the ministry usually publishes the comments received and its responses, and may then adopt the instrument, possibly revised, or not adopt it. This dashboard has not yet matched a promulgated instrument with exactly this name. This is not a forecast of the outcome.